Please login to the form below

Not currently logged in
Email:
Password:

Brian McNamara promoted to head of Novartis OTC

Appointment comes in wake of OTC recalls in US

Novartis has promoted Brian McNamara from president Novartis OTC Americas to head of its entire over-the-counter division.

McNamara replaces Naomi Kelman who Novartis said had decided to leave the company. She had only been in the position since March 2011 after joining from Johnson & Johnson (J&J).

In a statement, Joseph Jimenez, CEO of Novartis, thanked Kelman for her work, and welcomed McNamara as someone who will “provide strong leadership, focusing on growing our priority brands, consistently meeting our quality standards, and improving performance in key emerging markets”.

McNamara has been at Novartis OTC since 2004, when he joined as senior VP and general manager of OTC North America.

He spent three years in the position before moving to Europe as president and region head of Novartis OTC Europe.

Prior to his time at Novartis, he spent 16 years at Procter and Gamble, working in both manufacturing management and brand management.

His appointment comes just two months after Novartis recalled batches of four OTC products in the US following complaints of chipped and broken pills as well as well as inconsistent clearance practices for bottle packaging at a its Lincoln, Nebraska, manufacturing plant.

Novartis temporarily suspended operations at the facility following a warning letter from the US Food and Drug Administration (FDA).

GlaxoSmithKline (GSK) has also been affected by issues at the plant, and was forced to recall nearly 400,000 bottles of its blood pressure treatment DynaCirc CR that made there.

5th March 2012

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....
Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...